A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Chang, Jenny C. (Key Personnel)
Darcourt, Jorge (Key Personnel)
Geyer, Charles E. (Key Personnel)
Niravath, Polly A. (Key Personnel)

Houston Methodist

Project: Clinical Trial

Status	Not started